8. OVERVIEW OF THYROID CANCER CLASSIFICATION IN THE WORLD AND IN VIETNAM
Main Article Content
Abstract
This scoping review summarized the classification of thyroid cancer diagnosis worldwide and in Vietnam in the period 2009 to 2019. A total of 8 guidelines worldwide and Vietnam were analyzed in this review, revealing that the cytological classification across these guidelines is largely consistent, including the following categories: non-diagnostic/unsatisfactory, benign, atypia of undetermined significance/follicular lesion of undetermined significance, suspicious for malignancy, and malignant. The reclassification of certain follicular variants of papillary thyroid carcinoma cases as non-invasive follicular thyroid neoplasm with papillary-like nuclear features has led to changes in treatment approaches, reducing the number of patients undergoing aggressive cancer therapies while better aligning with the benign prognosis of these lesions. The transition from AJCC 7 to AJCC 8 has had a significant impact on clinical practice, providing more accurate treatment guidance for thyroid cancer patients. Updating and integrating international guidelines into clinical practice is crucial in enhancing diagnostic accuracy, improving prognosis, and optimizing treatment quality for thyroid cancer patients.
Article Details
Keywords
Thyroid cancer, diagnostic classification, guidelines
References
[2] Davies L, Welch H.G, Increasing Incidence of Thyroid Cancer in the United States, 1973-2002, JAMA, 2006, 295 (18), 2164-2167.
[3] Bray F, Ferlay J, Soerjomataram I et al, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA: A Cancer Journal for Clinicians, 2018, 68 (6), 394-424.
[4] Rahib L, Smith B.D, Aizenberg R et al, Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States, Cancer Res, 2014, 74 (11), 2913.
[5] 704-viet-nam-fact-sheets.pdf.
[6] Baker S.R, Bhatti W.A, The thyroid cancer epidemic: Is it the dark side of the CT revolution? European Journal of Radiology, 2006, 60 (1), 67-69.
[7] Davies L, Morris L.G.T, Haymart M et al, American association of clinical endocrinologists and american college of endocrinology disease state clinical review: the increasing incidence of thyroid cancer, Endocrine Practice, 2015, 21 (6), 686-696.
[8] Kitahara C.M, Sosa J.A, The changing incidence of thyroid cancer, Nature Reviews Endocrinology, 2016, 12 (11), 646-653.
[9] Theoharis C.G.A, Schofield K.M, Hammers L et al, The Bethesda Thyroid Fine-Needle Aspiration Classification System: Year 1 at an Academic Institution, Thyroid, 2009, 19 (11), 1215-1223.
[10] Cibas E.S, Ali S.Z, The 2017 Bethesda System for Reporting Thyroid Cytopathology, Thyroid, 2017, 27 (11), 1341-1346.
[11] Baloch Z.W, Seethala R.R, Faquin W.C et al, Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A changing paradigm in thyroid surgical pathology and implications for thyroid cytopathology, Cancer Cytopathol, 2016, 124 (9), 616-620.
[12] Bychkov A, Kakudo K, Hong S, Current Practices of Thyroid Fine-Needle Aspiration in Asia: A Missing Voice, J Pathol Transl Med, 2017, 51 (6), 517-520.
[13] Bychkov A, Jung C.K, Liu Z et al, Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features in Asian Practice: Perspectives for Surgical Pathology and Cytopathology, Endocr Pathol, 2018, 29 (3), 276-288.
[14] Vuong H.G, Ngo H.T.T, Bychkov A et al, Differences in surgical resection rate and risk of malignancy in thyroid cytopathology practice between Western and Asian countries: A systematic review and meta-analysis, Cancer Cytopathology, 2020, 128 (4), 238-249.
[15] Nixon I.J, Wang L.Y, Migliacci J.C et al, An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer, Thyroid, 2016, 26 (3), 373-380.
[16] Bộ Y tế, Hướng dẫn chẩn đoán và điều trị bệnh nội tiết - chuyển hóa, Nhà xuất bản Y học, Hà Nội, 2015.
[17] Bộ Y tế, Hướng dẫn chẩn đoán và điều trị một số bệnh ung bướu, Nhà xuất bản Y học, Hà Nội, 2020.